Laboratorios Farmacéuticos Rovi SA (ROVI)
BME
Closed
Oct 8, 2026
Day's Range
58.0552 wk Range
53.10Overview - ROVI - Laboratorios Farmacéuticos Rovi SA
Key Statistics
Valuation
Enterprise Value
3.02B
P/E (Trailing)
16.33
P/E (Forward)
17.61
PEG Ratio
17.61
Price / Sales (TTM)
3.91
Price / Book
4.31
EV / EBITDA
17.16
Profitability
Gross Margin
68.67%
Profit Margin
23.95%
Operating Margin
9.41%
Return on Assets
9.44%
Return on Equity
28.65%
Ownership
Shares Outstanding
51.14M
Float
16.20M
Held by Insiders
68.19%
Held by Institutions
17.02%
Price stats
Beta
0.23
50-Day Avg
58.61
200-Day Avg
67.02
Dividends
Payout Ratio
25.83%
Frequency
Annual
Analyst Consensus
9 analysts
Average price target
€ 74.36Market Cap - ROVI - Laboratorios Farmacéuticos Rovi SA
Peers - ROVI - Laboratorios Farmacéuticos Rovi SA
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BME.
- ROVIBMELaboratorios Farmacéuticos Rovi SA3.02BMarket Cap+4.23%52-week change16.34P/E (Trailing)23.95%Profit Margin
- ALMBMEAlmirall, S.A.2.28BMarket Cap-6.86%52-week change37.29P/E (Trailing)5.11%Profit Margin
- FAEBMEFaes Farma, S.A.1.43BMarket Cap+4.99%52-week change16.80P/E (Trailing)11.83%Profit Margin
- RJFBMELaboratorio Reig Jofre SA214.20MMarket Cap-7.66%52-week change32.63P/E (Trailing)2.05%Profit Margin
- LABBMELabiana Health S.A.51.78MMarket Cap+33.44%52-week change16.94P/E (Trailing)3.36%Profit Margin
- PARBMEParlem Telecom Company de Telecomunicacions, S.A.38.22MMarket Cap-265.91%52-week change-3.77P/E (Trailing)-8.98%Profit Margin
Profile Summary - ROVI - Laboratorios Farmacéuticos Rovi SA
About
Laboratorios Farmacéuticos Rovi SA is a Spanish biotechnology and pharmaceutical company specializing in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. Founded in 1946, it operates through two primary segments: Manufacturing, focused on contract development and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
